Showing results (151-160 of 217) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|December 10, 2025
ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumorsLaura Solé, Eric Canton, María Maqueda, et al.
JAMA Oncology|January 13, 2018
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical TrialLuca Gianni, Mauro Mansutti, Antonio Anton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicinFederico Rojo, Irene González-Navarrete, Rafael Bragado, et al.
Blood Advances|October 19, 2022
Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapyJuan Jose Rodríguez-Sevilla, Concepción Fernández-Rodríguez, Leyre Bento, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 TrialJoana Vidal, David Casadevall, Beatriz Bellosillo, et al.
Annals of Hematology|January 24, 2024
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronologyMarta Garrote, Mónica López-Guerra, Juan Carlos García-Pagán, et al.
Blood Advances|February 22, 2022
Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNANieves Garcia-Gisbert, Sara Garcia-Ávila, Brayan Merchán, et al.
Cancer Cell|September 14, 2010
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemiaLluis Espinosa, Severine Cathelin, Teresa D'Altri, et al.
Blood Advances|February 18, 2021
Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signatureSamah Alimam, William Villiers, Richard Dillon, et al.
Blood|August 18, 2012
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subcloneAnna L Godfrey, Edwin Chen, Francesca Pagano, et al.
Pageof 22